Efficacy
Initial clinical response
Comparable initial clinical response rate with DIFICID vs vancomycin at end of 10-day treatment
(a) CI (confidence interval) was derived using Wilson score method.
DIFICID®
(fidaxomicin) tablets, for oral use
Efficacy
(a) CI (confidence interval) was derived using Wilson score method.
DIFICID is a macrolide antibacterial drug indicated in adults (≥18 years of age) for treatment of Clostridium difficile–associated diarrhea (CDAD).
To reduce the development of drug-resistant bacteria and maintain the effectiveness of DIFICID and other antibacterial drugs, DIFICID should be used only to treat infections that are proven or strongly suspected to be caused by C difficile.